AJP - Gastrointestinal and Liver Physiology, Vol 268, Issue 6 1012-G1016, Copyright © 1995 by American Physiological Society

ARTICLES

Secretin at physiological doses inhibits gastric motility via a vagal afferent pathway

Y. Lu and C. Owyang
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109, USA.

Secretin is an important modulator of gastric motility. In this study, we investigated the site(s) and mechanism(s) of action of secretin to inhibit gastric motility, using an in vivo rat model. Intragastric pressure response to graded doses of secretin was recorded in anesthetized rats by a balloon attached to a catheter passed through an incision in the duodenum into the body of the stomach. The intragastric pressure was set at 10 cmH2O with balloon distension. Intravenous infusion of secretin (1.4, 2.8, 5.6, 11.2, and 22.4 pmol.kg-1.h-1) decreased intragastric pressure in a dose-dependent manner. The threshold dose was 2.8 pmol.kg-1.h-1, and the effective dose at 50% (ED50) was 5.6 pmol.kg-1.h-1, which produced physiological levels of plasma secretin. Pretreatment with hexamethonium (10 mg/kg) markedly reduced gastric motor response to secretin (5.6 pmol.kg-1.h-1). Bilateral truncal vagotomy also significantly diminished gastric motor responses to secretin. In contrast, secretin (5.6 pmol.kg-1.h-1) had no effect on gastric contraction evoked by electrical vagal stimulation (1.25-5 Hz) or carbachol (10(-6) to 3 x 10(-5) M). These observations indicate that physiological concentrations of secretin act via stimulation of presynaptic cholinergic neurons in a vagally mediated pathway. In subsequent studies, we demonstrated that perivagal treatment 4 days before with the sensory neurotoxin, capsaicin, abolished gastric motor response to secretin but did not affect contraction evoked by electrical vagal stimulation. Similarly, we also showed that gastroduodenal application of capsaicin for 30 min also markedly reduced gastric response to secretin. These observations indicate that physiological doses of secretin act on vagal afferent pathways originating from the gastroduodenal mucosa to induce gastric relaxation.

This article has been cited by other articles:

				S.-Y. Zhou, Y.-X. Lu, H. Yao, and C. Owyang Spatial organization of neurons in the dorsal motor nucleus of the vagus synapsing with intragastric cholinergic and nitric oxide/VIP neurons in the rat Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1201 - G1209. [Abstract] [Full Text] [PDF]

				S.-Y. Zhou, Y.-X. Lu, and C. Owyang Gastric relaxation induced by hyperglycemia is mediated by vagal afferent pathways in the rat Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1158 - G1164. [Abstract] [Full Text] [PDF]

				Y. Li, X. Wu, H. Yao, and C. Owyang Secretin activates vagal primary afferent neurons in the rat: evidence from electrophysiological and immunohistochemical studies Am J Physiol Gastrointest Liver Physiol, October 1, 2005; 289(4): G745 - G752. [Abstract] [Full Text] [PDF]

				Y.-X. Lu and C. Owyang Duodenal acid-induced gastric relaxation is mediated by multiple pathways Am J Physiol Gastrointest Liver Physiol, June 1, 1999; 276(6): G1501 - G1506. [Abstract] [Full Text] [PDF]

				H. Y. Kwon, T.-M. Chang, K. Y. Lee, and W. Y. Chey Vagus nerve modulates secretin binding sites in the rat forestomach Am J Physiol Gastrointest Liver Physiol, April 1, 1999; 276(4): G1052 - G1058. [Abstract] [Full Text] [PDF]

				C. D. Ulrich II, P. Wood, E. M. Hadac, E. Kopras, D. C. Whitcomb, and L. J. Miller Cellular distribution of secretin receptor expression in rat pancreas Am J Physiol Gastrointest Liver Physiol, December 1, 1998; 275(6): G1437 - G1444. [Abstract] [Full Text] [PDF]

				P. Holzer II. The elusive action of capsaicin on the vagus nerve Am J Physiol Gastrointest Liver Physiol, July 1, 1998; 275(1): G8 - G13. [Abstract] [Full Text] [PDF]